Non-availability of insulin in resource-limited settings, lack of compliance, emergence of adverse effects, risk of hypoglycemia and the need for self-monitoring of blood sugar levels, restrict the usage of insulin in real-world settings [19]. This evidence concerns the gene INS and Hypoglycemia.